IGF-1 DES 1mg Injection

IGF-1 DES (Insulin-like Growth Factor-1 Des(1-3)) is a truncated version of the IGF-1 peptide, lacking the first three amino acids at the N-terminus. This structural modification prevents the peptide from binding to IGF-binding proteins (IGFBPs), making it significantly more potent and biologically active than standard IGF-1.

This product is marketed as an allopathic injectable intended for medical or scientific evaluation of growth-promoting effects, particularly on muscle tissue.

Core Research Highlights

In clinical and laboratory research, IGF-1 DES is studied for:

• Muscle Hyperplasia: Unlike standard IGF-1, DES is highly effective at stimulating the proliferation of satellite cells, potentially leading to the formation of new muscle fibers rather than just the growth of existing ones.

• Receptor Affinity: Because it does not bind to IGFBPs, nearly all of the circulating peptide is available to bind to the IGF-1 receptors, resulting in a much stronger localized response.

• Localized Growth: Research often focuses on "site-specific" growth, as the peptide has a very short half-life (approximately 20–30 minutes), meaning its effects are largely concentrated where it is applied.

• Metabolic Signaling: It is used to model the growth-promoting effects of Human Growth Hormone (HGH) and its role in tissue repair and recovery.

Technical Specifications

Preparation and Usage Information

• Dosage: According to the supplier, this product should only be used as per a doctor's prescription.

• Administration: It is typically supplied as an injectable solution for precise administration in research or clinical settings.

• Minimum Order: The supplier (JSR Healthcare) indicates a Minimum Order Quantity (MOQ) of 150 boxes.

Storage and Safety Guidelines

To maintain the structural integrity of the truncated peptide:

• Storage Environment: Store in a cool and dry place.

• Temperature Sensitivity: Like most IGF-1 analogs, exposure to high heat or light can cause the peptide bonds to degrade, rendering the compound inactive.

• Safety Warning: This product is an allopathic medicine and should only be handled by qualified professionals. It is not intended for unsupervised self-administration.